Risk acceptance in multiple sclerosis patients on natalizumab treatment.
<h4>Objective</h4>We aimed to investigate the ability of natalizumab (NTZ)-treated patients to assume treatment-associated risks and the factors involved in such risk acceptance.<h4>Methods</h4>From a total of 185 patients, 114 patients on NTZ as of July 2011 carried out a co...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24340060/pdf/?tool=EBI |